Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Intracranial Bypass of Posterior Inferior Cerebellar Artery Aneurysms: Indications, Technical Aspects, and Clinical Outcomes.

Bonda DJ, Labib M, Katz JM, Ortiz RA, Chalif D, Setton A, Langer DJ, Dehdashti AR.

Oper Neurosurg (Hagerstown). 2017 Oct 1;13(5):586-595. doi: 10.1093/ons/opx064. Erratum in: Oper Neurosurg (Hagerstown). 2017 Dec 1;13(6):766.

PMID:
28922886
2.

Human prion diseases: surgical lessons learned from iatrogenic prion transmission.

Bonda DJ, Manjila S, Mehndiratta P, Khan F, Miller BR, Onwuzulike K, Puoti G, Cohen ML, Schonberger LB, Cali I.

Neurosurg Focus. 2016 Jul;41(1):E10. doi: 10.3171/2016.5.FOCUS15126. Review.

3.

The Recent Revolution in the Design and Manufacture of Cranial Implants: Modern Advancements and Future Directions.

Bonda DJ, Manjila S, Selman WR, Dean D.

Neurosurgery. 2015 Nov;77(5):814-24; discussion 824. doi: 10.1227/NEU.0000000000000899. Review.

4.

Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass.

Bonda DJ, Wang X, Lee HG, Smith MA, Perry G, Zhu X.

Neurosci Bull. 2014 Apr;30(2):243-52. doi: 10.1007/s12264-013-1424-x. Epub 2014 Apr 15. Review.

5.

Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance.

Bonda DJ, Stone JG, Torres SL, Siedlak SL, Perry G, Kryscio R, Jicha G, Casadesus G, Smith MA, Zhu X, Lee HG.

J Neurochem. 2014 Jan;128(1):162-72. doi: 10.1111/jnc.12380. Epub 2013 Aug 21.

6.

Nanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming!

Bonda DJ, Liu G, Men P, Perry G, Smith MA, Zhu X.

CNS Neurol Disord Drug Targets. 2012 Feb;11(1):81-5. Review.

7.
8.

The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations.

Bonda DJ, Lee HG, Camins A, Pallàs M, Casadesus G, Smith MA, Zhu X.

Lancet Neurol. 2011 Mar;10(3):275-9. doi: 10.1016/S1474-4422(11)70013-8. Review.

9.

Role of metal dyshomeostasis in Alzheimer's disease.

Bonda DJ, Lee HG, Blair JA, Zhu X, Perry G, Smith MA.

Metallomics. 2011 Mar;3(3):267-70. doi: 10.1039/c0mt00074d. Epub 2011 Feb 7. Review.

10.

Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease.

Bonda DJ, Mailankot M, Stone JG, Garrett MR, Staniszewska M, Castellani RJ, Siedlak SL, Zhu X, Lee HG, Perry G, Nagaraj RH, Smith MA.

Redox Rep. 2010;15(4):161-8. doi: 10.1179/174329210X12650506623645.

11.

Mitochondrial Drugs for Alzheimer Disease.

Bonda DJ, Wang X, Gustaw-Rothenberg KA, Perry G, Smith MA, Zhu X.

Pharmaceuticals (Basel). 2009 Dec 23;2(3):287-298.

12.

Pathological implications of cell cycle re-entry in Alzheimer disease.

Bonda DJ, Lee HP, Kudo W, Zhu X, Smith MA, Lee HG.

Expert Rev Mol Med. 2010 Jun 29;12:e19. doi: 10.1017/S146239941000150X. Review.

13.

Oxidative stress in Alzheimer disease: a possibility for prevention.

Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA.

Neuropharmacology. 2010 Sep-Oct;59(4-5):290-4. doi: 10.1016/j.neuropharm.2010.04.005. Epub 2010 Apr 13. Review.

PMID:
20394761
14.

Biomarkers in Alzheimer's disease: past, present and future.

Gustaw-Rothenberg K, Lerner A, Bonda DJ, Lee HG, Zhu X, Perry G, Smith MA.

Biomark Med. 2010 Feb;4(1):15-26. Review.

15.

Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies.

Bonda DJ, Wang X, Perry G, Smith MA, Zhu X.

Drugs Aging. 2010 Mar 1;27(3):181-92. doi: 10.2165/11532140-000000000-00000. Review.

16.

Novel therapeutics for Alzheimer's disease: an update.

Bonda DJ, Lee HP, Lee HG, Friedlich AL, Perry G, Zhu X, Smith MA.

Curr Opin Drug Discov Devel. 2010 Mar;13(2):235-46. Review.

17.

Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease.

Bonda DJ, Evans TA, Santocanale C, Llosá JC, Viña J, Bajic V, Castellani RJ, Siedlak SL, Perry G, Smith MA, Lee HG.

Aging (Albany NY). 2009 Apr;1(4):382-8.

18.

Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study.

Gustaw-Rothenberg KA, Siedlak SL, Bonda DJ, Lerner A, Tabaton M, Perry G, Smith MA.

Exp Gerontol. 2010 Jan;45(1):47-52. doi: 10.1016/j.exger.2009.10.003. Epub 2009 Oct 9.

19.

The X-chromosome instability phenotype in Alzheimer's disease: a clinical sign of accelerating aging?

Bajić VP, Spremo-Potparević B, Zivković L, Bonda DJ, Siedlak SL, Casadesus G, Lee HG, Smith MA.

Med Hypotheses. 2009 Dec;73(6):917-20. doi: 10.1016/j.mehy.2009.06.046. Epub 2009 Jul 31.

20.

Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease.

Thakur A, Siedlak SL, James SL, Bonda DJ, Rao A, Webber KM, Camins A, Pallàs M, Casadesus G, Lee HG, Bowser R, Raina AK, Perry G, Smith MA, Zhu X.

Int J Clin Exp Pathol. 2008 Jan 1;1(2):134-46.

Supplemental Content

Loading ...
Support Center